Jennifer E. Schwartz, MD
Bone Marrow Transplant | Hematology - Oncology
Accepting New Patients
Schedule an Appointment
Already a Patient? Connect on My IU Health
- Biography
- Insurance
- Locations
- Specialties & Details
- Clinical Trials
- Related Stories
Biography
Dr. Jennifer E. Schwartz specializes in Cancer Treatment for Blood and Bone Marrow Stem Cell Transplant & Immune Cell Therapy Program. Dr. Schwartz earned her medical degree at McGill University. She then completed a residency at McGill University, Jewish General Hospital, Montreal, Canada and a fellowship at the University of Pittsburgh Cancer Institute.
Dr. Schwartz's office is at Blood and Bone Marrow Stem Cell Transplant & Immune Cell Therapy Program, 1030 West Michigan St, Indianapolis, IN 46202. In addition to English, she speaks French.
Insurance
Insurance plans accepted by this provider are below.
Blue Cross and Blue Shield
Community Health Alliance
Deaconess OneCare
First Health Network
Lutheran Preferred
Majestic Care Management I-SNP
Medicaid (Traditional)
Medicare (Traditional)
MultiPlan/PHCS
Physicians Health Plan of Northern Indiana (PHP)
Sagamore Health Network
SHO Direct
Southern Indiana Health Organization (SIHO) Inspire/PPO
VA Community Care Network
Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.
Locations
Specialties & Details
Specialties:
Bone Marrow Transplant, Hematology - Oncology
Conditions & Treatments:
Bone Marrow and Stem Cell Transplantation, Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders
Additional Languages:
French
Education
School of Medicine:
McGill University, Montreal, Canada
Residency:
McGill University, Jewish General Hospital, Montreal, Canada
Fellowship:
University of Pittsburgh Cancer Institute, Pittsburgh, PA
Hospitals & Affiliations
Hospital Privileges:
IU Health Methodist/IU Health University
Physician Group:
IU Health Medical Group
Research
Research Publications
* Information provided by PubMed
Related Services
Clinical Trials
Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.
A randomized, double-blind, multicenter, Phase 3 study to evaluate efficacy and safety of belumosudil in combination with corticosteroids versus placebo in combination with corticosteroids in participants at least 12 years of age with newly diagnosed chronic graft versus host disease (cGVHD)
View DetailsRelated Stories
Patient Stories
Read More
Simon Cancer Center patients sing their way through Taylor Swift concert
IU Health Simon Cancer Center — One was surprised by a ticket, the other was thril...
Patient Stories
Read More
Swiftie fan: ‘I’m in my Bone Marrow Transplant Era’
IU Health Simon Cancer Center — This 22-year-old college student was on her way to...
Patient Stories
Read More
From a deer stand, to more than 100 hospital stays; patient battles leukemia
IU Health Simon Cancer Center — Dustin Flanigan has made more hospital visits than...